RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
CANADIAN DAILY STOCK REPORT
Corporate Wire Date: 06 November 2018 14:48 EST
ORIGINAL ANNOUNCEMENT [Text]
VANCOUVER, Nov. 06, 2018
Appointment of Dr. Goessens-Rueck strengthens management team and fulfils commitment to promote female leadership in biotech
VANCOUVER, Nov. 06, 2018 - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and or...